Latest Naproxen Stories

DUBLIN, Ireland, June 10, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/l3jllv/naproxen_sodium) has announced the addition of the "Naproxen Sodium (CAS 26159-34-2) Market Research Report 2013" [http://www.researchandmarkets.com/research/l3jllv/naproxen_sodium ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Naproxen Sodium (CAS 26159-34-2) Market Research Report 2013 presents...

Michael Harper for redOrbit.com – Your Universe Online A new study conducted by researchers at the University of Oxford has found that common painkillers can slightly increase the risk of heart problems in the long run. Common medications, such as ibuprofen and diclofenac were specifically noted in the study as being “equally dangerous” as Vioxx, a drug which has been removed from the market in the US due to its potentially dangerous effects. The Oxford researchers point out...

In Honor of Mother's Day, Campaign Looks to Raise $200,000 for WomenHeart and Awareness Among 42 Million Women With or at Risk of Heart Disease MORRISTOWN, N.J., May 7, 2013 /PRNewswire/ -- Bayer HealthCare, the makers of Bayer® Aspirin, WomenHeart: The National Coalition for Women with Heart Disease, and actress, singer and author Vanessa Williams today announce their partnership to launch Handbags & Hearts, a national campaign that leverages the link between women and their...

MADISON, Tenn., May 7, 2013 /PRNewswire/ -- Since 2007, the total cost of diabetes treatment in the United States has risen from $174 billion to $245 billion. Nearly 26 million adults and children currently live with the disease. Per capita medical expenditures now total $7,900. Chronic pain and neuropathy necessitate a steady regimen of prescription pain relief medications, which is one of the more significant factors contributing these numbers. These findings are the result of a...

MISSISSAUGA, ON, March 5, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX:NRI) announced today that its U.S. licensing partner, Mallinckrodt, the Pharmaceuticals Business of Covidien (NYSE:COV), has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following the review of Mallinckrodt's New Drug Application (NDA) for diclofenac sodium topical solution, 2% w/w (PENNSAID 2%). In the letter, the FDA requires that Mallinckrodt successfully...

Safe alternative pain relief offers immediate healthcare solutions and long-term savings MADISON, Tenn., Feb. 28, 2013 /PRNewswire/ -- A recently completed study finds that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) pose costly dangers for senior citizens. "Actuarial Cost Profile of Pain Management Using Prescription NSAIDs" documents the fast-growing financial toll linked to NSAID toxicity and side effects. Vireo Systems, Inc., which specializes in safe, effective pain relief...

Diclofenac most commonly used non-steroidal anti-inflammatory drug in 15 countries, listed on 74 national drug lists, despite cardiovascular risks A study in this week's PLOS Medicine finds that the painkiller diclofenac (a non-steroidal anti-inflammatory drug (NSAID) in the same class as aspirin) is the most commonly used NSAID in the 15 countries studied and is included in the essential medicines lists of 74 low-, middle- and high-income countries, despite its known tendency to cause...

MADISON, Tenn., Nov. 27, 2012 /PRNewswire/ -- She has appeared on the big screen in films such as The Blind Side and Scary Movie 5. Her numerous television credits include a recurring role on "Drop Dead Diva," and co-starring roles in "Army Wives," "The Gates," and "The Game." But now, actress Ashley LeConte Campbell is undertaking a new role: She is the official spokesperson of AminoActiv®, the natural, non-toxic anti-inflammatory pain reliever consumers are increasingly choosing...

Lee Rannals for redOrbit.com – Your Universe Online Taking painkillers increases your risk of death if you are a heart attack survivor, according to a study published in the journal Circulation. Scientists found that those heart attack survivors who take painkillers not only increased their chances of having a second heart attack, but also increased their risk of dying. Over-the-counter painkillers like ibuprofen and naproxen, as well as prescription drugs like Celebrex, are the...

MISSISSAUGA, ON, Sept. 5, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the United States Patent Office has issued United States Patent # 8,252,838 relating to compositions and methods of using PENNSAID(®) (diclofenac sodium topical solution) 2.0% w/w (PENNSAID 2% Patent).  The patent expires on April 21, 2028. Nuvo's U.S. licensing...